What STRATA Skin Sciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 0 | 3 |
| Total trades | 0 | 5 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 5,000 |
| Disposed | 0 | 14,094 |
| Net activity | +0 | −9,094 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rubinstein Samuel | Director | Nov 18 | Open-market buy · P | +2,832 | $1.41 | +$3.99K | 8,766 |
| Rubinstein Samuel | Director | Nov 18 | Open-market buy · P | +2,168 | $1.40 | +$3.04K | 5,934 |
| Rubinstein Samuel | Director | Nov 17 | Open-market sale · S | −1,394 | $1.36 | −$1.9K | 3,766 |
| Rubinstein Samuel | Director | Nov 17 | Open-market sale · S | −7,200 | $1.34 | −$9.65K | 5,160 |
| Rubinstein Samuel | Director | Nov 17 | Open-market sale · S | −5,500 | $1.32 | −$7.26K | 12,360 |
| Accelmed Growth Partners, L.p. | 10% owner | Jul 15 | Open-market buy · P | +230,573 | $3.14 | +$724K | 1,441,835 |
| Rafaeli Dolev | Chief Executive Officer | Jul 15 | Open-market buy · P | +19,100 | $3.14 | +$60K | 143,156 |
| Geiger Uri | Director | Jul 15 | Open-market buy · P | +230,573 | $3.14 | +$724K | 1,441,835 |
| Gov Shmuel | COO | Dec 01 | Open-market buy · P | +4,800 | $0.47 | +$2.26K | 20,000 |
| Gov Shmuel | COO | Dec 01 | Open-market buy · P | +300 | $0.46 | +$138 | 15,200 |
| Gov Shmuel | COO | Dec 01 | Open-market buy · P | +562 | $0.45 | +$253 | 14,900 |
| Gov Shmuel | COO | Dec 01 | Open-market buy · P | +14,338 | $0.44 | +$6.31K | 14,338 |
| Rubinstein Samuel | Director | Nov 16 | Open-market sale · S | −1,000 | $0.32 | −$320 | 177,602 |
| 22NW, Lp | 10% owner | Aug 16 | Open-market buy · P | +1,853,056 | $0.55 | +$1.02M | 5,369,954 |
| Moccia Robert Joseph | Chief Executive Officer | Aug 10 | Open-market buy · P | +42,000 | $0.67 | +$28.3K | 235,300 |
| Lesovitz Christopher | Chief Financial Officer | Aug 10 | Open-market buy · P | +10,000 | $0.67 | +$6.65K | 38,282 |
| Lesovitz Christopher | Chief Financial Officer | Aug 10 | Open-market buy · P | +5,151 | $0.68 | +$3.5K | 28,282 |
| Walker Patricia S | Director | Jul 05 | Grant / award · A | +36,408 | $1.03 | +$37.5K | 89,894 |
| Strang Douglas | Director | Jul 05 | Grant / award · A | +33,981 | $1.03 | +$35K | 86,877 |
| Rubinstein Samuel | Director | Jul 05 | Grant / award · A | +33,981 | $1.03 | +$35K | 178,602 |
Loading...